These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34563656)

  • 1. Influence of active pharmaceutical ingredient structures on Hansen solubility parameters.
    Petříková E; Patera J; Gorlová O
    Eur J Pharm Sci; 2021 Dec; 167():106016. PubMed ID: 34563656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of solubility parameters for characterization of pharmaceutical excipients.
    Adamska K; Voelkel A; Héberger K
    J Chromatogr A; 2007 Nov; 1171(1-2):90-7. PubMed ID: 17931639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hansen solubility parameter as a tool to predict cocrystal formation.
    Mohammad MA; Alhalaweh A; Velaga SP
    Int J Pharm; 2011 Apr; 407(1-2):63-71. PubMed ID: 21256944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse gas chromatographic determination of solubility parameters of excipients.
    Adamska K; Voelkel A
    Int J Pharm; 2005 Nov; 304(1-2):11-7. PubMed ID: 16183222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New procedure for the determination of Hansen solubility parameters by means of inverse gas chromatography.
    Adamska K; Bellinghausen R; Voelkel A
    J Chromatogr A; 2008 Jun; 1195(1-2):146-9. PubMed ID: 18502435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly loaded interactive mixtures for dry powder inhalers: prediction of the adhesion capacity using surface energy and solubility parameters.
    Wagner KG; Dowe U; Zadnik J
    Pharmazie; 2005 May; 60(5):339-44. PubMed ID: 15918581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of polymeric excipients on desupersaturation profiles of active pharmaceutical ingredients. 1: Polyethylene glycol.
    Schneider R; Taspinar L; Ji Y; Sadowski G
    Int J Pharm; 2020 May; 582():119317. PubMed ID: 32320721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data mining of solubility parameters for computational prediction of drug-excipient miscibility.
    Alhalaweh A; Alzghoul A; Kaialy W
    Drug Dev Ind Pharm; 2014 Jul; 40(7):904-9. PubMed ID: 23627441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility of pharmaceutical ingredients in triglycerides.
    Brinkmann J; Huxoll F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
    Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
    Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental consideration of the Hansen solubility parameters of as-produced multi-walled carbon nanotubes by inverse gas chromatography.
    Lim HJ; Lee K; Cho YS; Kim YS; Kim T; Park CR
    Phys Chem Chem Phys; 2014 Sep; 16(33):17466-72. PubMed ID: 25017729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis.
    Forster A; Hempenstall J; Tucker I; Rades T
    Int J Pharm; 2001 Sep; 226(1-2):147-61. PubMed ID: 11532578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds.
    Makoni PA; Ranchhod J; WaKasongo K; Khamanga SM; Walker RB
    Saudi Pharm J; 2020 Mar; 28(3):308-315. PubMed ID: 32194332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
    Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
    Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Determination of the Solubility Parameters of 1-Alkyl-3-methylimidazolium Bromide ([C
    Zhu QN; Wang Q; Hu YB; Abliz X
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemometric study of the excipients' influence on polymorphic-behavior. Mefenamic acid as case of study.
    Antonio M; Calvo NL; Maggio RM
    J Pharm Biomed Anal; 2019 Jun; 170():8-15. PubMed ID: 30901720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-Silico Screening of Lipid-Based Drug Delivery Systems.
    Brinkmann J; Exner L; Luebbert C; Sadowski G
    Pharm Res; 2020 Nov; 37(12):249. PubMed ID: 33230602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved group contribution parameter set for the application of solubility parameters to melt extrusion.
    Just S; Sievert F; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1191-9. PubMed ID: 23628829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.